Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Dasatinib - Generic Drug Details

« Back to Dashboard

What are the generic sources for dasatinib and what is the scope of dasatinib freedom to operate?

is the generic ingredient in two branded drugs marketed by Apotex Inc and Bristol Myers Squibb, and is included in two NDAs. There are six patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Dasatinib has one hundred and ten patent family members in thirty-nine countries.

There are eight drug master file entries for dasatinib. Two suppliers are listed for this compound.

Summary for Generic Name: dasatinib

Drug Master File Entries: see list8
Suppliers / Packagers: see list2
Bulk Api Vendors: see list93
Clinical Trials: see list106
Patent Applications: see list6,659
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dasatinib at DailyMed

Pharmacology for Ingredient: dasatinib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
TABLET;ORAL021986-001Jun 28, 2006ABRXYesNo6,596,746► SubscribeYY ► Subscribe
Bristol Myers Squibb
TABLET;ORAL021986-004May 30, 2008ABRXYesYes8,680,103► SubscribeY ► Subscribe
Bristol Myers Squibb
TABLET;ORAL021986-006Oct 28, 2010RXYesNo7,153,856► Subscribe ► Subscribe
Bristol Myers Squibb
TABLET;ORAL021986-005Oct 28, 2010RXYesNo7,125,875► Subscribe ► Subscribe
Apotex Inc
TABLET;ORAL202103-003Jun 10, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus